As Calls For Patent Sharing To Fight Pandemic Intensify, Manufacturing May Be Bigger Issue

19 Apr 2020

Scientists and lawyers ask companies to temporarily license their IP for free, as others advocate compulsory licenses; real issue may be the ability to make a COVID-19 treatment or vaccine widely available.

Patent Health Care Pharmaceuticals Innovation concept. — Groups want biopharma companies to share their intellectual property for COVID-19 battle

As Calls For Patent Sharing To Fight Pandemic Intensify, Manufacturing May Be Bigger Issue

More from Legal & IP

More from Pink Sheet